Arbutus Biopharma：Arbutus Biopharma Corporation (ABUS) Stock Price
Arbutus Biopharma Corporation (ABUS) Stock Price
FindthelatestArbutusBiopharmaCorporation(ABUS)stockquote,history,newsandothervitalinformationtohelpyouwithyourstocktradingand ...。其他文章還包含有：「AboutArbutus」、「ABUS-ArbutusBiopharmaCorporation」、「ArbutusBiopharma」、「ArbutusBiopharmaCorporation(ABUS)公司概況及事件」、「ArbutusBiopharmaCorporation(ABUS)走勢圖」、「Home」、「InvestorRelations」、「Pipeline」、「PressReleases」
查看更多 離開網站
About Arbutus
https://www.arbutusbio.com
We are a clinical-stage biopharmaceutical company with deep virology expertise and an unwavering focus on curing conditions with unmet medical need. Today, we' ...
ABUS-Arbutus Biopharma Corporation
https://www.moneydj.com
Arbutus Biopharma Corporation(ABUS.US)總部設在加拿大Burnaby，是一家生物製藥公司，在加拿大和美國開發和銷售治療慢性乙型肝炎（HBV）感染的療法。該公司還正在開發基於 ...
Arbutus Biopharma
https://en.wikipedia.org
Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA ...
Arbutus Biopharma Corporation (ABUS) 公司概況及事件
https://hk.finance.yahoo.com
查看Arbutus Biopharma Corporation (ABUS) 的公司概況，包括業務摘要、行業/板塊資訊、員工人數、企業管治、高級行政人員及其薪酬。
Arbutus Biopharma Corporation(ABUS) 走勢圖
https://tw.stock.yahoo.com
Arbutus Biopharma Corporation · 成交1.84 · 開盤1.82 · 最高1.86 · 最低1.81 · 一年內最高3.1500 · 買進1.8 · EPS (TTM)-0.4600 · PE Ratio(TTM). - ...
Home
https://www.arbutusbio.com
Arbutus is a virology-focused biotech on a mission to bring our clinical and pre-clinical assets to the patients that need them most.
Investor Relations
https://investor.arbutusbio.co
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and ...
Pipeline
https://www.arbutusbio.com
Our dynamic portfolio of virology assets includes a pipeline focused on curing HBV. Today, we have several active clinical studies, including approaches ...
Press Releases
https://investor.arbutusbio.co
Summary ToggleArbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at ...